Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
Heartflow (Nasdaq: HTFL) announced management will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco on March 3, 2026.
Rhea-AI Summary
Heartflow (Nasdaq: HTFL) announced management will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco on March 3, 2026.
The presentation is scheduled for 10:45 a.m. PT / 1:45 p.m. ET, with a live webcast and archived replay available via the company's Investor Relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – HTFL
In the Feb 19 session, HTFL gained 1.31%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- March 3, 2026
- Morgan Stanley Technology, Media & Telecom Conference presentation date
- Presentation time PT
- 10:45 a.m. PT
- Scheduled time for Heartflow fireside chat
- Presentation time ET
- 1:45 p.m. ET
- Scheduled time for Heartflow fireside chat
Historical Context
-
Expanded GAMEFILM registry to additional retired pro athletes using AI plaque analysis.
-
Aetna began nationwide coverage with new Category I CPT code and RVU structure.
-
Management presented at J.P. Morgan Healthcare Conference with webcast for investors.
-
ACC/AHA statements highlighted quantitative plaque assessment and Heartflow pathway in CAD care.
-
Large FFRCT analyses showed prognostic power and health‑economic savings in >90,000 patients.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
coronary artery disease (cad) medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & Telecom Conference. The presentation will take place in San Francisco, CA, on Tuesday, March 3, 2026, at 10:45 a.m. PT / 1:45 p.m. ET.
A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website at https://ir.heartflow.com.
About Heartflow’s Technology and Research
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by ACC/AHA guidelines and supported by more than 600 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 500,000 patients worldwide.1 Key benefits include:
- Proprietary data pipeline: Built from more than 160 million annotated CTA images, Heartflow’s data foundation powers advanced AI models that deliver highly accurate, reproducible insights across diverse patient populations.
- Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 200 studies assessing over 365,000 patients. Proven in real-world practice with reproducibility and accuracy, Heartflow’s coronary CTA image acceptance rates exceed
97% . - Seamless clinical integration via upgraded workflow: Heartflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
- Quality system, global security and patient-data integrity compliance: Heartflow meets or exceeds leading international standards, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001.
About Heartflow, Inc.
Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures. Discover how we’re shaping the future of cardiovascular care at heartflow.com.
Investor Contact
Nick Laudico
nlaudico@heartflow.com
Media Contact
Elliot Levy
elevy@heartflow.com
____________________
1Gulati, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation & Diagnosis of Chest Pain. J Am Coll Cardiol.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.